おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
CellScape
company
About
CellScape Corporation is focused on developing a comprehensive non-invasive prenatal genetic test for women.
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $1.60M
- Industries
- Biotechnology,Genetics,Health Care,Health Diagnostics
- Founded date
- Jan 1, 2008
- Number Of Employee
- 11 - 50
- Operating Status
- Active
CellScape Corporation (formerly Saryna Medical Corp) is a privately funded company headquartered in Newark, California, in the heart of the biotech corridor of the San Francisco Bay Area. The Company has developed whole fetal cell technology to transform prenatal genetic testing using a simple blood test. Their vision is to make comprehensive prenatal genetic testing available to every woman without requiring an invasive procedure that might put the fetus at risk. Their leadership team is accomplished in bringing innovative, cost-effective medical and molecular diagnostics to market.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$10.90M
CellScape has raised a total of
$10.90M
in funding over 2 rounds. Their latest funding was raised on
Feb 1, 2012 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 1, 2012 | Series B | $9.30M | 1 | — | — | Detail |
| Dec 1, 2010 | Series A | $1.60M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
CellScape is funded by 1 investors.
Zygote Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Zygote Ventures
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
